Published in Brain on August 01, 1998
Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol (2000) 2.99
Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc Natl Acad Sci U S A (2007) 1.76
Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis. Glia (2002) 1.74
Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination. Ann Neurol (2010) 1.47
Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis. PLoS One (2015) 1.39
Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J Neuroimaging (2005) 1.36
Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One (2011) 1.35
Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol (2004) 1.31
MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol (2005) 1.26
Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. J Exp Med (2004) 1.25
Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis. Surg Neurol Int (2011) 1.19
Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc Natl Acad Sci U S A (2004) 1.12
Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis. Am J Pathol (2003) 1.11
Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis. Am J Pathol (2006) 1.09
MR spectroscopy indicates diffuse multiple sclerosis activity during remission. J Neurol Neurosurg Psychiatry (2009) 1.07
Energy failure in multiple sclerosis and its investigation using MR techniques. J Neurol (2011) 1.06
White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis. J Cereb Blood Flow Metab (2012) 1.04
Brainstem 1H nuclear magnetic resonance (NMR) spectroscopy: marker of demyelination and repair in spinal cord. Ann Neurol (2009) 0.98
1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS. Mult Scler (2000) 0.96
High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis: correlation between metabolic alterations and diagnostic MR imaging criteria. J Neurol (2007) 0.95
Diffusion tensor imaging of the optic tracts in multiple sclerosis: association with retinal thinning and visual disability. J Neuroimaging (2011) 0.95
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics. Brain (2014) 0.94
Demyelination and axonal preservation in a transgenic mouse model of Pelizaeus-Merzbacher disease. EMBO Mol Med (2010) 0.94
Myelin repair: the role of stem and precursor cells in multiple sclerosis. Philos Trans R Soc Lond B Biol Sci (2008) 0.93
Reduced expression of plasma membrane calcium ATPase 2 and collapsin response mediator protein 1 promotes death of spinal cord neurons. Cell Death Differ (2010) 0.93
Mediators of oligodendrocyte differentiation during remyelination. FEBS Lett (2011) 0.93
Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study. J Neurol (2005) 0.93
Prevention of axonal injury using calpain inhibitor in chronic progressive experimental autoimmune encephalomyelitis. Brain Res (2008) 0.92
MR spectroscopy of cervical spinal cord in patients with multiple sclerosis. Neuroradiology (2004) 0.92
Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. J Immunol (2015) 0.90
Cell therapy for multiple sclerosis. Neurotherapeutics (2011) 0.89
Stem cells, progenitors and myelin repair. J Anat (2005) 0.89
A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis. J Neurol (2010) 0.86
Mice devoid of Tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Neuropathol Exp Neurol (2012) 0.86
N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry. J Neurol (2007) 0.85
Transgenic expression of viral capsid proteins predisposes to axonal injury in a murine model of multiple sclerosis. Brain Pathol (2011) 0.85
Evaluation of corticospinal axon loss by fluorescent dye tracing in mice with experimental autoimmune encephalomyelitis. J Neurosci Methods (2007) 0.85
Metabolic mapping of deep brain structures and associations with symptomatology in autism spectrum disorders. Res Autism Spectr Disord (2014) 0.84
Mechanisms of neuronal damage in multiple sclerosis and its animal models: role of calcium pumps and exchangers. Biochem Soc Trans (2007) 0.84
Imaging genetics of structural brain connectivity and neural integrity markers. Neuroimage (2009) 0.83
Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy. BMC Neurol (2004) 0.82
Can we prevent or treat multiple sclerosis by individualised vitamin D supply? EPMA J (2013) 0.82
Metabolomic approach to human brain spectroscopy identifies associations between clinical features and the frontal lobe metabolome in multiple sclerosis. Neuroimage (2013) 0.82
Oligodendroglia and neurotrophic factors in neurodegeneration. Neurosci Bull (2013) 0.81
Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis. J Neuroimmunol (2014) 0.81
In vivo metabolite differences between the basal ganglia and cerebellum of the rat brain detected with proton MRS at 3T. Psychiatry Res (2007) 0.81
Limited TCF7L2 expression in MS lesions. PLoS One (2013) 0.80
Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis. Stem Cells (2014) 0.79
Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis. Mult Scler Int (2011) 0.79
Investigation of nerve injury through microfluidic devices. J R Soc Interface (2013) 0.79
Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis. Neuroradiology (2007) 0.79
Novel pathologic findings in patients with Pelizaeus-Merzbacher disease. Neurosci Lett (2016) 0.78
Optical coherence tomography (OCT) in optic neuritis and multiple sclerosis. Rev Neurol (Paris) (2010) 0.77
Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis. Cell Med (2014) 0.76
Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies. Neuropharmacology (2016) 0.76
Variants of ST8SIA1 are associated with risk of developing multiple sclerosis. PLoS One (2008) 0.76
Proteomic strategies in multiple sclerosis and its animal models. Proteomics Clin Appl (2007) 0.76
Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders? Mol Neurobiol (2015) 0.76
Proton magnetic resonance spectroscopy assessment of metabolite status of the anterior cingulate cortex in chronic pain patients and healthy controls. J Pain Res (2017) 0.76
Axonopathy in the Central Nervous System Is the Hallmark of Mice with a Novel Intragenic Null Mutation of Dystonin. Genetics (2016) 0.75
Early B-cell Factor gene association with multiple sclerosis in the Spanish population. BMC Neurol (2005) 0.75
Peripapillary retinal nerve fiber layer thickness in bipolar disorder. Graefes Arch Clin Exp Ophthalmol (2015) 0.75
Increased axonal expression of nectin-1 in multiple sclerosis plaques. Neurol Sci (2012) 0.75
Site and size of multiple sclerosis lesions predict enhanced or decreased female orgasmic function. J Neurol (2015) 0.75
Motor evoked potentials in multiple sclerosis patients without walking limitation: amplitude vs. conduction time abnormalities. J Neurol (2007) 0.75
Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med (2003) 12.09
Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci (2003) 10.44
fMRI resting state networks define distinct modes of long-distance interactions in the human brain. Neuroimage (2005) 8.61
Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage (2002) 8.03
Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim Biophys Acta (1982) 7.13
Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med (1984) 6.74
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med (1986) 6.58
A different approach to RNA sequencing. Nature (1978) 5.90
Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome. A 31P nuclear magnetic resonance study. Lancet (1984) 4.42
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
Dissociating pain from its anticipation in the human brain. Science (1999) 4.36
Changes in connectivity profiles define functionally distinct regions in human medial frontal cortex. Proc Natl Acad Sci U S A (2004) 4.19
PCR detection, identification to species level, and fingerprinting of Campylobacter jejuni and Campylobacter coli direct from diarrheic samples. J Clin Microbiol (1997) 3.59
Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol (1986) 3.45
Geminivirus strain demarcation and nomenclature. Arch Virol (2008) 3.21
Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn (1992) 3.14
The efficiency of translation termination is determined by a synergistic interplay between upstream and downstream sequences in Saccharomyces cerevisiae. J Mol Biol (1995) 2.97
Rapid identification by PCR of the genus Campylobacter and of five Campylobacter species enteropathogenic for man and animals. Res Microbiol (1997) 2.89
Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cereb Cortex (2007) 2.83
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol (2001) 2.75
Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA (1999) 2.74
Phylogeny of the genus Pseudomonas: intrageneric structure reconstructed from the nucleotide sequences of gyrB and rpoD genes. Microbiology (2000) 2.73
Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci (2001) 2.68
Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy. Ann Neurol (1999) 2.67
Normalized accurate measurement of longitudinal brain change. J Comput Assist Tomogr (2001) 2.67
Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region. Brain (2003) 2.57
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology (1999) 2.49
Identification of a pathogenicity island, which contains genes for virulence and avirulence, on a large native plasmid in the bean pathogen Pseudomonas syringae pathovar phaseolicola. Proc Natl Acad Sci U S A (1999) 2.39
Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score--the CoLaus Study. Diabetologia (2009) 2.32
Acoustics of children's speech: developmental changes of temporal and spectral parameters. J Acoust Soc Am (1999) 2.30
Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol (2001) 2.28
Human BAC ends quality assessment and sequence analyses. Genomics (2000) 2.25
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology (2005) 2.24
Changes in white matter microstructure during adolescence. Neuroimage (2007) 2.22
Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med (1985) 2.22
Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR. Magn Reson Med (1984) 2.21
Surgical outcome in patients with epilepsy and dual pathology. Brain (1999) 2.19
Creatinine: a review. Clin Chem (1980) 2.16
Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology (2006) 2.10
Integrating evidence-based practices and the recovery model. Psychiatr Serv (2001) 2.10
VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest (1999) 2.08
Identification of dna components required for induction of cotton leaf curl disease. Virology (2001) 2.05
Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation (2000) 2.04
Major polyadenylated transcripts of cassava latent virus and location of the gene encoding coat protein. EMBO J (1985) 2.04
Longitudinal changes in grey and white matter during adolescence. Neuroimage (2009) 2.03
Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res (1993) 2.01
Molecular subtyping scheme for serotypes HS1 and HS4 of Campylobacter jejuni. J Clin Microbiol (1995) 2.01
CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am J Pathol (1997) 2.00
Susceptibility-induced loss of signal: comparing PET and fMRI on a semantic task. Neuroimage (2000) 1.97
Restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, India, by use of direct-repeat probe. J Clin Microbiol (1995) 1.95
Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology (2003) 1.94
Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med (1995) 1.92
Revised proposal for naming geminiviruses. Arch Virol (2000) 1.92
TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice. Nat Immunol (2001) 1.92
Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol (2001) 1.91
Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol (1982) 1.91
Slow-growing Rhizobium japonicum comprises two highly divergent symbiotic types. J Bacteriol (1985) 1.89
Selective reductions in prefrontal glucose metabolism in murderers. Biol Psychiatry (1994) 1.88
Energetics of human muscle: exercise-induced ATP depletion. Magn Reson Med (1986) 1.83
Defining a left-lateralized response specific to intelligible speech using fMRI. Cereb Cortex (2003) 1.82
Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol (1983) 1.80
A protein linked to the 5' termini of both RNA components of the cowpea mosaic virus genome. Nucleic Acids Res (1978) 1.79
Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. AJNR Am J Neuroradiol (2006) 1.78
DNA forms of the geminivirus African cassava mosaic virus consistent with a rolling circle mechanism of replication. Nucleic Acids Res (1991) 1.78
Quantitative fMRI assessment of the differences in lateralization of language-related brain activation in patients with temporal lobe epilepsy. Neuroimage (2003) 1.77
Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity. J Biol Chem (2000) 1.76
Two types of 16S rRNA gene are found in Campylobacter helveticus: analysis, applications and characterization of the intervening sequence found in some strains. Microbiology (1994) 1.74
Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med (1996) 1.71
Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia (2000) 1.70
Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain (1998) 1.68
Human infection with avian influenza A(H7N9) virus re-emerges in China in winter 2013. Euro Surveill (2013) 1.68
Novel Campylobacter-like organism resembling Helicobacter fennelliae isolated from a boy with gastroenteritis and from dogs. J Clin Microbiol (1993) 1.67
A unique virus complex causes Ageratum yellow vein disease. Proc Natl Acad Sci U S A (2000) 1.66
The neurohumoral axis in congestive heart failure. Ann Intern Med (1984) 1.66
Learning about pain: the neural substrate of the prediction error for aversive events. Proc Natl Acad Sci U S A (2000) 1.66
Fluorescent amplified-fragment length polymorphism analysis of an outbreak of group A streptococcal invasive disease. J Clin Microbiol (1998) 1.66
Subviral agents associated with plant single-stranded DNA viruses. Virology (2006) 1.66
Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol (1995) 1.65
Maximal exercise tolerance as a therapeutic end point in heart failure--are we relying on the right measure? Am J Cardiol (1994) 1.64
Rapid, accurate and simultaneous noninvasive assessment of right and left ventricular mass with nuclear magnetic resonance imaging using the snapshot gradient method. J Am Coll Cardiol (1992) 1.64
Alphavirus neurovirulence: monoclonal antibodies discriminating wild-type from neuroadapted Sindbis virus. J Virol (1985) 1.64
Incidence of acquired demyelination of the CNS in Canadian children. Neurology (2009) 1.63
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63
Comparative evaluation of molecular typing of strains from a national epidemic due to Salmonella brandenburg by rRNA gene and IS200 probes and pulsed-field gel electrophoresis. J Clin Microbiol (1994) 1.63
Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain (2000) 1.62